This post has not been vetted or endorsed by BuzzFeed's editorial staff. BuzzFeed Community is a place where anyone can create a post or quiz. Try making your own!
Dendreon Investors Will Finally See if Controversial Prostate Cancer Treatment, Provenge Will Make It to the Market
Dendreon Corp. (DNDN) has reached the endline. The biotechnology company’s investors will finally see if the controversial prostate cancer treatment, Provenge, is likely to make it to the market after waiting for two years. The outcome will decide the fate of the Seattle drug developer.
